SOL Bio - Crunchbase Company Profile & Funding

Q: Where is SOL Bio's headquarters?

SOL Bio is located in Seoul, Seoul-t'ukpyolsi, South Korea.

Q: Who invested in SOL Bio?

SOL Bio has 5 investors including Stick Ventures And SJ Investment Partners.

Q: When was the last funding round for SOL Bio?

SOL Bio closed its last funding round on obfuscated from a Series A round.

Overview

SOL Bio

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About SOL Bio

CB Rank

143003

SOL Bio is an exosome-based cancer diagnostics company that researches and develops in vitro diagnostic products.

Founded

obfuscation

Private

Series A

Seoul, Seoul-t'ukpyolsi, South Korea

11-50

www.sol-bio.com

Biotechnology

Health Diagnostics

Product Design

Funding Rounds

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Details

Legal Name

SOL Bio Corp.

Also Known As

솔바이오 주식회사

Operating Status

Active

Company Type

For Profit

Phone Number

+82 2 466 2796

Contact Email

info@sol-bio.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Exosome Isolation Technology

A technique using Ca²⁺ switch-on/off binding reaction to sequentially isolate exosome subpopulations for early cancer diagnosis.

Neutra Release™

A patented method to isolate tumor-derived exosomes from blood for early-stage malignant melanoma diagnosis.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A
obfuscated obfuscation	Series A - SOL Bio	4	obfuscated obfuscation	—	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Stick Ventures	—	Series A - SOL Bio	—
Stick Ventures	—	Series A - SOL Bio	—
Stick Ventures	—	Series A - SOL Bio	—
Stick Ventures	—	Series A - SOL Bio	—
Stick Ventures	—	Series A - SOL Bio	—